PhD-qualified scientific leader with more than 15 years of R and D experience across medical diagnostics, biotechnology, pharmaceuticals and academia, including eight years leading scientific teams. Principal R and D Scientist and Group Lead with 11 direct reports and accountability for team performance, capability development, resource planning and delivery across complex diagnostic-biomarker programmes. Combines assay-development expertise across biochemical, molecular and analytical platforms with technical governance, validation strategy, root-cause problem solving and regulated-quality experience spanning GMP, GLP and GCP. Led a 2.3 million dollar clinical biomarker programme to successful completion of a key milestone in June 2026, having influenced Executive Directors and investors, and worked across biology, analytical science, software, clinical and external SME partners. Keen to further develop and apply technical and managerial skill set across challenging science projects that have tangible potential of improving health and wellbeing.